Bio-Rad Laboratories | BIO - Current Assets


Bio-Rad Laboratories reported $3.02B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio Techne USD 744.4M 56.35M Jun/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Danaher USD 13.38B 554M Jun/2026
General Electric Aerospace USD 39.7B 664M Jun/2026
Illumina USD 2.83B 96M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Laboratory Of America USD 3.81B 743.9M Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Pacific Biosciences Of California USD 338.64M 30.88M Jun/2026
Quest Diagnostics USD 2.84B 278M Jun/2026
Repligen USD 1.2B 39.19M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Siemens EUR 65.14B 3.81B Jun/2026
Standard Biotools USD 521.45M 67.19M Mar/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Tosoh JPY 835.36B 37.3B Jun/2026
Waters USD 3.9B 186M Jun/2026